SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is experiencing heightened volatility as investors debate its future trajectory, with some suggesting it's overbought while others point to ongoing global instability and central bank activity as drivers for further gains. Community discussions revolve around potential pullbacks versus continued upward momentum, linking GLD's performance to factors like government shutdowns, trade tensions, and the debasement of fiat currencies. There's also chatter about GLD's relationship with other assets like Bitcoin and US Treasuries.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending following Q3 revenue announcements and increased FY2025 guidance, with much of the community discussion focused on the potential impact of DefenCath sales and the Melinta acquisition. Some investors are expressing frustration with the stock's performance despite positive news, while others remain optimistic about the company's long-term prospects and potential catalysts, such as a possible deal with DaVita and developments related to TLPH.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors discuss potential catalysts including multi-year contracts with auto manufacturers and potential government investment. Community members are closely watching for news of asset sales and the impact of steel tariffs, alongside speculation about a foreign partnership. Discussions also revolve around the company's debt and its positioning in the steel market.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

HIMS is trending due to a mix of factors, including a recent CEO stock sale sparking concerns among investors, and broader market reactions to potential shifts in weight-loss drug pricing. The community is actively debating the impact of these events, with some viewing the dip as a buying opportunity and others questioning the company's valuation and leadership. Discussions also include potential short squeeze opportunities and the company's expansion into new markets.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ ($LAES) is trending following the unveiling of their new Quantum Shield QS7001 chip at a New York conference, sparking excitement about the company's potential in the quantum security space. The community is discussing the chip's hardware-embedded post-quantum cryptography and comparing LAES to other quantum computing stocks, highlighting its strong financials and government contracts.

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

RAPT Therapeutics Inc

RAPT Therapeutics is trending following positive Phase II data, leading to a trading halt and sparking community discussion around a potential 'crazy spike' upon unhalting. Bullish sentiment is further fueled by analyst upgrades and price target increases, with some speculating about a potential retail squeeze. The community is also closely watching for further developments regarding RAPT's next-generation CCR4 antagonist.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Celcuity is trending due to positive Phase 3 trial results for its breast cancer therapy, showing a significant reduction in disease progression. The community is buzzing about the potential for FDA approval and a possible buyout, while some anticipate a potential pullback after the initial surge. Overall sentiment suggests strong conviction in the stock's future, driven by the promising data and potential for the drug to become a new standard of care.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon's stock is trending due to a widespread AWS outage impacting numerous services and applications, sparking concerns about the reliability of centralized infrastructure. The community is discussing the extent of the disruption and its potential financial repercussions, while also questioning Amazon's ability to maintain its competitive edge in cloud computing and AI amid the issues.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is trending as the company transitions from Bitcoin mining to include AI compute, hiring an industry veteran to lead the effort. The community speculates about potential 'giga-campus opportunities' and partnerships, with some drawing comparisons to IREN's AI infrastructure plans. Bullish sentiment is fueled by anticipation of news and potential short squeezes.

BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded by Liew Choong-Chin on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.

BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is trending due to a recently announced strategic partnership, sparking excitement among investors. The community is focused on the potential impact of the partnership, especially given the stock's low float and history as a runner. Some traders believe the stock is due for a significant upward move, while others caution about potential dilution and volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$EVFM lol @EdgarDerby I’m not bullish. You’re proving my point. Anyone who bought this at $2-$3.00 would be an IDIOT right now if they didn’t average down. 

I averaged down so now due to the acquisition I’m breaking even. If I didn’t average down I’d be losing thousands with an 0.09¢ average. You’re a moron to be here complaining about your losses and NOT average down for a guaranteed buyout.

@AOCashMoney lol....20cents...there are people who bought this at over $2.00 and $3.00. Either way, go FYS stumping and stanning for this POS company. YOu are full of shit that you are &quot;even&quot; now.   
 
I just hate this company and pieces of sh!t like you who still have the nerve and gall to post &quot;bullish.&quot; It&#39;s suspect

StockTwits Web

Edgar Derby

StockTwits for iOS

Evofem Biosciences Inc

 I’m not bullish. You’re proving my point. Anyone who bought this at $2-$3.00 would be an IDIOT right now if they didn’t average down. 

I averaged down so now due to the acquisition I’m breaking even. If I didn’t average down I’d be losing thousands with an 0.09¢ average. You’re a moron to be here complaining about your losses and NOT average down for a guaranteed buyout.

AOCashMoney

@EdgarDerby how? By believing that it’s better to break even before the merger than to lose 99.99%?! 

Please explain that. You seem like a paid basher now. Why so much negative emotion with INACTION?

 how? By believing that it’s better to break even before the merger than to lose 99.99%?! 

Please explain that. You seem like a paid basher now. Why so much negative emotion with INACTION?

Banging the &quot;just average down&quot; drum on a stock that goes NOWHERE, doesn&#39;t really make anyone&#39;s money back. Do you understand that people sunk money into this at 2.00/3.00? There is zero upside here...sure, averaging down works if the SP eventually GOES UP. But, news flash, this pile of shit only goes DOWN. So, sinking more and more money into this hasn&#39;t helped anyone yet. I don&#39;t believe for a second that you are &quot;even now.&quot; Further, what upside resides in a merger with another POS company? ADTX is just another scam like EVFM...so, who gives AF about this merger? Why would there be any UPSIDE at all? I mean look at ADTX...it has lost soooooo much just in the last month.  
 
These people are actual criminals

Banging the "just average down" drum on a stock that goes NOWHERE, doesn't really make anyone's money back. Do you understand that people sunk money into this at 2.00/3.00? There is zero upside here...sure, averaging down works if the SP eventually GOES UP. But, news flash, this pile of shit only goes DOWN. So, sinking more and more money into this hasn't helped anyone yet. I don't believe for a second that you are "even now." Further, what upside resides in a merger with another POS company? ADTX is just another scam like EVFM...so, who gives AF about this merger? Why would there be any UPSIDE at all? I mean look at ADTX...it has lost soooooo much just in the last month.  
 
These people are actual criminals

@EdgarDerby it’s literally guaranteed to go up from 0.012 - 0.016¢ due to the merger. So there you have it.

 it’s literally guaranteed to go up from 0.012 - 0.016¢ due to the merger. So there you have it.

@AOCashMoney LOL...&quot;guaranteed to be a merger,&quot; huh? So, you&#39;re on here asking, for nearly a year, about whether the merger is even really happening, but now its a lock, a &quot;guarantee.&quot; If it&#39;s a guarantee, why tf you in here asking and wondering about if its gonna happen? FOH...you know the answer...these are two CRIMINAL, SCUMBAG companies whose whole existence is about fleecing retail. ADTX will R/S AGAIN, before they &quot;merge&quot;

 LOL..."guaranteed to be a merger," huh? So, you're on here asking, for nearly a year, about whether the merger is even really happening, but now its a lock, a "guarantee." If it's a guarantee, why tf you in here asking and wondering about if its gonna happen? FOH...you know the answer...these are two CRIMINAL, SCUMBAG companies whose whole existence is about fleecing retail. ADTX will R/S AGAIN, before they "merge"